生脉联合血栓通预防深静脉血栓形成的临床观察

The clinical observation of combined with Shengmai and Xueshuantong to prevent the deep venous thrombosis

目的:探讨生脉联合血栓通预防深静脉血栓形成(deep venous thrombus,DVT)的效果。方法:回顾性分析2007年2月～2010年3月入住我院ICU接受监护治疗的同时接受活血化瘀治疗的成年患者360例,360例患者被分成三组,生脉组(A组)、血栓通组(B组)及联合用药组(C组),分别给予生脉、血栓通及联合用药治疗,观察治疗期间DVT的发生率、发生时间和出血倾向的发生率。结果:A组、B组、C组DVT的发生率分别为5.00%、4.17%和1.67%;DVT发生时间分别为(25.32±5.22)d,(27.04±4.27)d和(45.17±7.36)d;出血倾向发生率分别为1.67%、0.83%和1.67%。结论:生脉联合血栓通能减少、延缓长期卧床重症患者深静脉血栓形成的发生,效果优于单一用药的效果,安全性好。

Objective：To approach the efficacy of combined with Shengmai and Xueshuantong to prevent the deep venous thrombosis.Methods：The retrospective analysis of 360 cases adult patients to dissipate blood stasis treatment in our hospital intensive care unit from February 2007 to March 2010 were conducted.360 cases patients were divided into 3 groups,Shengmai group（group A）,Xueshuantong group（group B）and combination group（group C）,all of them were given Shengmai,Xueshuantong and combination therapy.We observed the incidence of DVT,time of occurrence and the inci dence of bleeding tendency during treatment.Results：The DVT incidence of Group A,group B and group C were 5.00%,4.17% and 1.67%;the occurrence time of DVT were（25.32±5.22） days,（27.04±4.27） days,（45.17±7.36） days;the incidence of bleeding tendency were 1.67%,0.83% and 1.67%.Conclusion：Shengmai combined with Xueshuantong can reduce and delay the long-term bedridden critically ill patients to occur deep venous thrombosis,the effect is better than single agent,and it is safety.